C

Core Laboratories Inc
F:HJ1

Watchlist Manager
Core Laboratories Inc
F:HJ1
Watchlist
Price: 9.7 EUR 7.18%
Market Cap: €452.8m

Wall St Price Targets

HJ1 Price Targets Summary
Core Laboratories Inc

Wall Street analysts forecast HJ1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HJ1 is 21.21 EUR with a low forecast of 15.43 EUR and a high forecast of 29.4 EUR.

Lowest Forecast
Price Target
15.43 EUR
59% Upside
Average Forecast
Price Target
21.21 EUR
119% Upside
Highest Forecast
Price Target
29.4 EUR
203% Upside
Core Laboratories Inc Competitors:
Price Targets
ELCO
Eleco PLC
90% Upside
NJR
New Jersey Resources Corp
11% Upside
RNGR
Ranger Energy Services Inc
20% Upside

Revenue
Forecast

-5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 2 years is 2%.

Gross Profit
Forecast

-9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been -9%. The projected CAGR for the next 1 year is 4%.

Operating Income
Forecast

-12% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-12% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 2 years is 1%.

Pre-Tax Income
Forecast

-13% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-13% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -13%. The projected CAGR for the next 2 years is 5%.

Net Income
Forecast

-14% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
-14% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -14%. The projected CAGR for the next 2 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HJ1's stock price target?
Price Target
21.21 EUR

According to Wall Street analysts, the average 1-year price target for HJ1 is 21.21 EUR with a low forecast of 15.43 EUR and a high forecast of 29.4 EUR.

What is the Revenue forecast for Core Laboratories Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 2 years is 2%.

What is the Gross Profit forecast for Core Laboratories Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been -9%. The projected CAGR for the next 1 year is 4%.

What is the Operating Income forecast for Core Laboratories Inc?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 2 years is 1%.

What is the Pre-Tax Income forecast for Core Laboratories Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -13%. The projected CAGR for the next 2 years is 5%.

What is the Net Income forecast for Core Laboratories Inc?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Net Income has been -14%. The projected CAGR for the next 2 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett